What is the role of FDG-PET in the initial staging of breast cancer?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 3, 2008, Pages 472-474

  Belohlavek, Otakar ^a  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CASE REPORT; EDITORIAL; FEMALE; FOLLOW UP; HUMAN; MASTECTOMY; PARANEOPLASTIC SYNDROME; POSITRON EMISSION TOMOGRAPHY; PYREXIA IDIOPATHICA; VASCULITIS;

BREAST NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 43349083563     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0643-7     Document Type: Editorial

References (6)

1. Çermik TF, Mavi A, Basu S, Alavi A. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med 2008;35: DOI 10.1007/s00259-007-0580-5.
2. Basu S, Mavi A, Çermik T, Dadparvar S, Houseni M, Bural G, et al. Characteristics of physiological FDG uptake in the normal breast tissue with regard to patient physiology in dual time point FDG-PET: comparison with proven malignant lesions. Eur J Nucl Med 2007;34:S246.
3. Heusner TA, Freudenberg LS, Kuehl H, Hauth EAM, Veit P, Forsting M, et al. Whole-body PET/CT mammography: a feasibility study. Eur J Nucl Med 2007;34:S247.
4. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET study group. J Clin Oncol 2004;22:277-285.
5. Feinendegen LE, Pollycove M. Biologic responses to low doses of ionizing radiation: detriment versus hormesis. Part 1. Dose responses of cells and tissues. J Nucl Med 2001;42:17N-27N.
6. Keller PJ, Subramaniam R. FDG-PET/CT staging in inflammatory breast cancer. Eur J Nucl Med 2007;34:S247.